Connect with us

Life Sciences

Gestalt and Pramana Announce Strategic Partnership to Offer Customers Advanced, AI-Enabled Image Analysis in End-to-End Solution

Gestalt Diagnostics a leading provider of artificial intelligence (AI) powered digital pathology solutions, and Pramana, an AI-enabled health tech company…

Published

on

This article was originally published by AITHORITY
Gestalt and Pramana Announce Strategic Partnership to Offer Customers Advanced, AI-Enabled Image Analysis in End-to-End Solution

Gestalt Diagnostics a leading provider of artificial intelligence (AI) powered digital pathology solutions, and Pramana, an AI-enabled health tech company modernizing the pathology sector, announced a strategic collaboration to provide an AI-powered, end-to-end digital pathology platform for laboratories, health systems and academic medical centers.

Recommended AI: AiThority Interview with Marc Bolitho, CEO of Recogni

The integration between Pramana’s SpectralHT scanning solution and Gestalt’s PathFlow solution enables fast, accurate and automated slide scanning with AI algorithms and image analysis applied directly to the whole slide images. The advanced technology can be applied during the processing phase or with Gestalt’s Image Management System post scan. Pramana’s DICOM images are managed directly within Gestalt’s platform. This relationship enhances each company’s technological solution by providing streamlined integration between the Pramana scanners and Gestalt’s award-winning digital pathology solution, PathFlow.

“I am excited about the relationship between our two companies. It embodies our philosophy of continuing to bring new methods of diagnostic and research support directly to pathologists, scientists and academics,” said Lisa-Jean Clifford, Gestalt COO & Chief Strategy Officer. “When forward-thinking technology companies work together to bring solutions that can significantly impact the tools being used to diagnose and treat patients, train residents and pathologists, and provide a foundation for scientists to build new solutions, then we are making meaningful strides in advancing healthcare globally.”

Recommended AI: AiThority Interview with Alan Holland, CEO and Founder of Keelvar

“Digital pathology is crossing the technology adoption chasm and being actively pursued beyond the researchers,” said Prasanth Perugupalli, Chief Product Officer of Pramana. “Pramana is pioneering Digital Pathology 2.0 – the new standard in whole slide imaging – designed to empower pathologists, automate lab operations, and enable algorithm developers. Our collaboration with Gestalt will provide labs and pathologists the quality they have come to expect in whole slide imaging and raise confidence in digital adoption.”

Recommended AI: AiThority Interview with Bartley Richardson, Director, Cybersecurity Engineering and R&D at NVIDIA

[To share your insights with us, please write to sghosh@martechseries.com]

The post Gestalt and Pramana Announce Strategic Partnership to Offer Customers Advanced, AI-Enabled Image Analysis in End-to-End Solution appeared first on AiThority.

diagnostics


artificial intelligence

Life Sciences

Wittiest stocks:: Avalo Therapeutics Inc (NASDAQ:AVTX 0.00%), Nokia Corp ADR (NYSE:NOK 0.90%)

There are two main reasons why moving averages are useful in forex trading: moving averages help traders define trend recognize changes in trend. Now well…

Continue Reading
Life Sciences

Spellbinding stocks: LumiraDx Limited (NASDAQ:LMDX 4.62%), Transocean Ltd (NYSE:RIG -2.67%)

There are two main reasons why moving averages are useful in forex trading: moving averages help traders define trend recognize changes in trend. Now well…

Continue Reading
Life Sciences

Asian Fund for Cancer Research announces Degron Therapeutics as the 2023 BRACE Award Venture Competition Winner

The Asian Fund for Cancer Research (AFCR) is pleased to announce that Degron Therapeutics was selected as the winner of the 2023 BRACE Award Venture Competition….

Continue Reading

Trending